Novartis IndiaNSE:NOVARTIND +1.93%62 Days Inventory is 93.24 as of Mar. 2026, which is 9% below its 10-year median of 102.50. GuruFocus rates NSE:NOVARTIND with a GF Score™ of 62/100 and a GF Value™ of ₹642.38 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 923 Drug Manufacturers companies, Novartis India ranks better than 84.62% on this metric.
The historical rank and industry rank for Novartis India's Days Inventory or its related term are showing as below:
NSE:NOVARTIND'
s Days Inventory Range Over the Past 10 Years
Min: 77.36 Med: 102.5 Max: 130.05
Current: 85.69
During the past 13 years, Novartis India's highest Days Inventory was 130.05. The lowest was 77.36. And the median was 102.50.
NSE:NOVARTIND's Days Inventory is ranked better than 84.62% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs NSE:NOVARTIND: 85.69
Novartis India's Days Inventory
increased
from Mar. 2025 (76.09) to Mar. 2026 (93.24).
It might indicate that Novartis India's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Novartis India's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.98.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Novartis India's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.59.
Novartis India (NSE:NOVARTIND) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Novartis India's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Novartis India's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Novartis India Days Inventory Related Terms
Novartis India Days Inventory Historical Data
* Premium members only.
The historical data trend for Novartis India's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:NOVARTIND vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Novartis India's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Novartis India Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Novartis India's Days Inventory distribution charts can be found below:
* The bar in red indicates where Novartis India's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novartis India (NSE:NOVARTIND) has a Days Inventory of 93.24 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Novartis India and its competitors. This is near median its historical median of 102.50. Over the past decade, Novartis India's Days Inventory has ranged from 77.36 to 130.05. According to the industry distribution chart, Novartis India ranks #142 out of 923 companies in the Drug Manufacturers industry, placing it in the top 15.4%.
Is Novartis India's Days Inventory too high?
Novartis India's current Days Inventory of 93.24 is near median its 10-year median of 102.50. Over the past 10 years, this metric has ranged from a low of 77.36 to a high of 130.05. The Drug Manufacturers industry median Days Inventory is 164.48. Novartis India's value of 93.24 is 43.3% below this industry median. Based on the distribution chart, Novartis India ranks #142 out of 923 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Novartis India has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Novartis India's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Novartis India ranks #142 out of 923 companies for Days Inventory. This places Novartis India in the top 15% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.48. Novartis India's value of 93.24 is 43.3% below this benchmark. Historically, Novartis India's own Days Inventory has ranged from 77.36 to 130.05 over the past decade. While the company's 10-year median is 102.50 vs. the industry median of 164.48, Novartis India has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Novartis India's current Days Inventory of 93.24 is 43.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Novartis India and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Novartis India's current Days Inventory is 93.24, which is near median its own 10-year median of 102.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novartis India stock overvalued right now?
Based on GuruFocus' analysis, Novartis India (NSE:NOVARTIND) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹642.38, compared to a current price of ₹1,494.60 — trading 132.7% above its estimated fair value. The current Days Inventory is 93.24, which is near median its 10-year median of 102.50 and 43.3% below the Drug Manufacturers industry median of 164.48. Novartis India's overall GF Score™ is 62/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Novartis India (NSE:NOVARTIND), the current Days Inventory is 93.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Novartis India (NSE:NOVARTIND) Overvalued in 2026?
Based on GuruFocus' analysis, Novartis India stock appears to be overvalued.
The current stock price of ₹1,494.60 is trading 132.7% above its estimated GF Value™ of ₹642.38.
GuruFocus considers Novartis India to be Significantly Overvalued.
Key valuation signals for NSE:NOVARTIND:
Days Inventory: 93.24 (near median its 10-year median of 102.50)
GF Value™: ₹642.38 vs. price of ₹1,494.60 (132.7% above fair value)
Industry Position: 43.3% below the Drug Manufacturers median (#142 of 923)
No single metric tells the full story. See the NSE:NOVARTIND stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Novartis India Ltd is an Indian-based pharmaceutical company. The company is engaged in the trading of Drugs and Pharmaceuticals. It derives revenue from operations in India. The company operates in a single business segment, namely Pharmaceutical Business. Its Pharmaceutical business focuses on Bone and Pain, Transplantation Immunology, and Neurosciences.
62GF Score
Get the complete analysis for NSE:NOVARTIND
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:NOVARTIND has been successfully added to your 
